NCT00883662

Mirena Observational Program

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,725 (actual)
• Sponsor: Bayer · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Mirena is used for long-term in Kazakhstan, and in our observational program we would like to study patients distribution per indications of Mirena, and also patient compliance within a year after Mirena insertion. For patients with all approved indications for Mirena use: contraception, treatment of menorrhagia and protection from endometrial hyperplasia during estrogen replacement therapy

Conditions

• Contraception
• Menorrhagia
• Endometrial Hyperplasia
• Estrogen Replacement Therapy

Interventions

Type	Name	Description
DRUG	Levonorgestrel (Mirena, BAY86-5028)	Patients older than 18 years with previously taken decision of their gynecologist to insert Mirena according to registered indications

Timeline

• Start date: 2009-05-01
• Primary completion: 2014-04-01
• Completion: 2015-11-01
• First posted: 2009-04-20
• Last updated: 2016-09-30

Locations

1 site across 1 country: Kazakhstan